Biological Responses to Metal Implants
/
Lots of references to studies about Copper IUDs .
Read MoreStudies about
IUDs (Intra-Uterine Devices)
Assessment of reasons of discontinuation of long acting reversible contraceptives (LARC) among married women visiting at Holy Family Hospital Rawalpindi. JSOGP 2016
/
Read MoreReasons for discontinuation of IUD:
Bleeding Pattern (27.5%), Pain (25%), Weight Gain (5%); Other Reasons (42.5%)
Citizen Petition for Hormonal Contraceptives
/
Read More....The strongest data appear to be the deleterious effects of levonorgestrel-releasing IUDs on percent lean and fat body mass.
….Use of the levonorgestrel-releasing IUD, commonly used to treat abnormal bleeding in the perimenopause, increased the risk of developing breast cancer in postmenopausal women
One-year continuation of postpartum intrauterine contraceptive device: findings from a retrospective cohort study in India
/
Read MoreAmong women who had their PPCuIUD removed, almost two thirds (64.9%) cited associated side effects like bleeding, pain in abdomen and discharge as the primary reason for removal.
Steroid reservoir loss during removal of perforated Levonorgestrel 52 mg intrauterine device
/
Read MoreA 22-year-old G1P1 Caucasian female had hysteroscopic removal of a perforated intrauterine device during which the steroid reservoir of the intrauterine device was lost. Isolated steroid reservoirs are radiolucent on plain film radiography. We located the reservoir in the peritoneal cavity with magnetic resonance imaging and removed it via laparoscopy.
Pelvic pain and early IUD discontinuation: a prospective cohort study
/
Read MoreBaseline generalized pelvic pain may not be a risk factor for IUD discontinuation within one year of placement.
Society of Family Planning clinical recommendations: contraception after surgical abortion
/
Andrea Hsu Roe, Deborah Bartzb
Contraception Journal - January 1, 2019
September 06, 2018 - Published
IUDs can be safely placed at the time of surgical abortion and do not increase the risk of infection or perforation. IUD expulsion rates are significantly higher after second-trimester surgical abortion than after first-trimester surgical abortion, but expulsion rates after first-trimester surgical abortion may not differ significantly from interval placement.
Excerpts from Abstract
These recommendations present an evidence-based assessment of provision of contraceptives at the time of surgical abortion. Most methods of contraception, including the intrauterine devices (IUD), implant, depot medroxyprogesterone injection, oral contraceptive pill, contraceptive patch, monthly vaginal ring, barrier methods and some permanent methods, can be safely initiated immediately after first- or second-trimester surgical abortion. Provision of postabortion contraceptives, particularly IUDs and implants, substantially reduces subsequent unintended pregnancy. IUD insertion immediately following uterine aspiration is safe. While this may be associated with a higher risk of device expulsion than with interval placement, expulsion rates remain low, and this risk must be weighed against the fact that patients often do not receive their desired IUD at an interval insertion and therefore experience higher rates of subsequent unintended pregnancy. Many patients experience barriers that prevent access to the full spectrum of postabortion contraceptive options, particularly IUDs and implants. Advancements in health-systems-based point-of-care provision and policies are needed to improve comprehensive contraceptive availability following surgical abortion. These recommendations will address clinical considerations for postabortion contraceptive provision and recommend interventions to improve contraceptive access following uterine evacuation.
Read Entire Abstract at Contraception
Contraception
An International Reproductive Health Journal
Wishes to advance reproductive health through the rapid publication of the best and most interesting new scholarship regarding contraception and related fields such as abortion.
- 2018
- Abdominal Pain
- Abnormal Bleeding
- Access
- Allergies
- Anaphylaxis
- Anxiety & Depression
- Auto-immune Disease
- Back Pain
- Bacterial Vaginosis (BV)
- Bleeding
- blood clots
- Brain Fog
- Brain Swelling
- breast cancer
- Breastfeeding
- Cancer
- cervical cancer
- Choice
- Choking
- Coercion
- Copper 7
- Copper T
- Copper Toxicity
- Cost
- Difficulty Swallowing
- Digestive Issues
- Discharge
- Early Removal
- eczema
- Endometrial Cancer
- Expulsion
- Fatigue
- Fear
- Fertility
- Gene Mutation
- Gravigard
- hair loss
- Headache & Migraine
- Heart Palpitations
- High Blood Pressure
- HIV
- Improvement after Removal
- Increase in Use
- Inflammation
- Informed Consent
- Internet Forums
- Intolerences
- Irritability & Mood Changes
- Jaydess
- Kyleena
- Lung Cancer
- Menopausal Symptoms
- Migration
- Mirena
- Missing Strings
- MRI
- Muscle Pains & Aches
- Non-Use
- osteoporosis
- Ovarian Cancer
- Pain
- Pancreatic Cancer
- Paragard
- Paranoia
- Pelvic Pain
- Perforation
- PID & Infections
- Placement
- PMDD
- Post-Abortion
- Postpartum Insertion
- pregnancy
- Prostaglandins
- Rashes
- Reproductive Justice
- Rheumatoid Arthritis (RA)
- Self Removal
- Sex Life
- sexual dysfunction
- Shortness of Breath
- Skin Problems & Jaundice
- Skyla
- STI Risk
- Stroke & Heart Attack
- suicide
- Surgical Removal
- Tubal Ligation
- Vertigo & Dizziness
- Weight Gain
The Management of a patient with a fragmented intrauterine device embedded within the cervical canal - Case Report
/
Read MoreA 28-year-old woman presented with a malpositioned intrauterine device (IUD) that was fragmented and significantly entrenched within the cervical canal and myometrium. IUD malposition with concomitant device fragmentation and embedded segments, albeit rare, should be a consideration given the device's prevalence.
Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices
/
Read MoreBecause adolescents are at higher risk of sexually transmitted infections (STIs), obstetrician–gynecologists should continue to follow standard guidelines for STI screening. They should advise adolescents who choose LARC methods to use male or female condoms consistently (dual method use) to decrease the risk of STIs, including human immunodeficiency virus (HIV). Obstetrician–gynecologists should counsel all sexually active adolescents who do not seek pregnancy on the range of reversible contraceptive methods, including LARC, and should help make these contraceptives readily accessible to them.
Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer
/
Read MoreRecent levonorgestrel-IUD use may be associated with CIN2, a lesion with a high rate of regression, but not CIN3, which is considered a true pre-cancerous lesion. The observed association between levonorgestrel-IUDs and CIN2+ was modest but warrants further investigation. It may have clinical importance for contraceptive counseling if this finding is shown to be consistent across other studies and other populations.
Factors associated with low-lying intrauterine devices: a cross-sectional ultrasound study in a cohort of African-American women
/
Read MoreWomen who are obese may benefit from additional counseling and closer follow-up after IUD placement. Future research is warranted to investigate IUD placement and possible IUD migration among women who are obese.
Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study
/
Read MoreThe overall perforation rate was 2.1 per 1000 insertions for LNG-IUS users 1.6 per 1000 insertions for copper-IUD users……. LNG-IUS users had a borderline higher risk of perforation compared with copper-IUD users.
Forty-five (58%) of the 77 perforations were associated with suspected risk factors……
Breastfeeding…… and time since delivery remained significant risk factors in perforations detected after 12 months.
No perforations resulted in serious injury to intra-abdominal or pelvic structures.
Information sur le dispositif intra-utérin Mirena - Point d'information
/
Read MoreTout effet indésirable suspecté d’être lié à l’utilisation du dispositif intra-utérin Mirena peut être signalé, par les patientes ou les professionnels de santé, en tant qu’effet indésirable associé à un médicament sur https://solidarites-sante.gouv.fr/soins-et-maladies/signalement-sante-gouv-fr/ .
Chronic Systemic Toxicity Study of Copper Intrauterine Devices in Female Wistar Rats
/
The aim of this study was to evaluate the chronic systemic and local toxicity of a copper intrauterine device in a rat model. These results obtained at different dosages and long-term implantation provide solid data confirming the safety of long-term use of Cu-IUDs. However, the elevated leucocyte levels found in this study warrant further investigation.
Includes lots of references to other studies.
Read More
Jaydess IUS Study
/
Read MoreJaydess should be used with caution after specialist advice, or removal should be considered in women with existing or new severe headache, migraine, jaundice, severe arterial disease such as stroke or myocardial infarction, or marked increase in blood pressure.
Choice of contraception may influence rheumatoid arthritis autoimmunity risk
/
Read MoreWomen using intrauterine devices (IUDs) may be at increased risk for producing autoantibodies related to the risk of developing rheumatoid arthritis (RA), according to new research.
Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland
/
August 2014
Obstetrics & Gynecology
Migration of Intrauterine Devices: Radiologic Findings and Implications for Patient Care
/
Read MoreIntrauterine devices (IUDs) are a commonly used form of contraception worldwide. However, migration of the IUD from its normal position in the uterine fundus is a frequently encountered complication, varying from uterine expulsion to displacement into the endometrial canal to uterine perforation.